Africa Cancer Therapeutics Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
No. of Pages: 150 | Report Code: BMIRE00031438 | Category: Life Sciences
No. of Pages: 150 | Report Code: BMIRE00031438 | Category: Life Sciences
The Cancer Therapeutics Market size is expected to reach US$ 7,742.87 million by 2031 from US$ 4,174.35 million in 2024. The market is estimated to record a CAGR of 8.6% from 2025 to 2031.
The cancer therapeutics market in Africa is experiencing notable progress, driven by an increasing burden of cancer cases, an expanding healthcare infrastructure, and growing access to advanced medical treatments. Africa is home to diverse countries with varying healthcare systems and economic statuses, adding to the complexity of the region’s cancer therapeutics landscape complex. Cancer is becoming one of the leading causes of morbidity and mortality across the continent, with countries such as South Africa, Egypt, and Nigeria witnessing significant rises in cancer cases. However, challenges such as limited access to healthcare, insufficiency of early detection programs, and a lack of cancer awareness remain key barriers to cancer care.
Key segments that contributed to the derivation of the cancer therapeutics market analysis are therapy type, indication, and distribution channel.
A significant rise in cancer cases in the region drives the need for cancer therapeutics. According to the government of UAE, ~4,500 new cases of cancer are reported every year in the country. The International Agency for Research on Cancer stated that the UAE recorded 4,807 new cancer cases in 2020. As per GLOBOCAN 2020 data, the country recorded ~1,030 new breast cancer cases, representing 21.4% of all new cases. The demand for cancer treatments, both conventional and innovative, is surging due to increasing cancer cases, coupled with an aging population and lifestyle factors that contribute to cancer risks, such as smoking and poor dietary habits.
Governments of various countries of the Africa are investing heavily in healthcare infrastructure and cancer control programs. For instance, the government of Kuwait has been actively investing in efforts to enhance the cancer treatment infrastructure. The Ministry of Health (MOH) has prioritized cancer care by establishing specialized treatment centers such as the Kuwait Cancer Control Center, which provides a wide range of services, including chemotherapy and immunotherapy. In October 2021, the National Bank of Kuwait (NBK) launched an annual campaign during breast cancer awareness month to promote women's health. The campaign is part of the Bank's ongoing campaign to raise social awareness regarding breast cancer and promote its ways of prevention.
Based on region, the Africa cancer therapeutics market is further segmented into South Africa, Egypt, Algeria, and Nigeria. South Africa held the largest share in 2024.
South Africa is one of the major economies in the Middle East & Africa; the country had a GDP of US$ 377.78 billion in 2024. Healthcare accounts for ~8.5% of the national GDP, holding the second-largest share of the overall GDP of the country. As the government and private sectors increase funding to improve healthcare infrastructure, there is greater demand for therapeutics.
Cancer remains one of the leading causes of death in South Africa, with common types including breast, prostate, cervical, and lung cancer. According to the GLOBOCAN 2020 data, ~108,168 new cancer cases were diagnosed, and 56,802 cancer-related mortality occurred in the country in 2020. The South African government, through its public health system, has been working to tackle the rising burden of cancer by implementing a range of initiatives aimed at improving access to cancer care and encouraging innovations in cancer therapies.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 4,174.35 Million |
| Market Size by 2031 | US$ 7,742.87 Million |
| Global CAGR (2025 - 2031) | 8.6% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Therapy Type
|
| Regions and Countries Covered | Africa
|
Astellas Pharma Inc; Eli Lilly and Co; Novartis AG; Merck KGaA.; Johnson & Johnson; AstraZeneca; Pfizer Inc; Bristol Myers Squibb; F. Hoffmann-La Roche Ltd; and AbbVie Inc are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note:
All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
The Africa Cancer Therapeutics Market is valued at US$ 4,174.35 Million in 2024, it is projected to reach US$ 7,742.87 Million by 2031.
As per our report Africa Cancer Therapeutics Market, the market size is valued at US$ 4,174.35 Million in 2024, projecting it to reach US$ 7,742.87 Million by 2031. This translates to a CAGR of approximately 8.6% during the forecast period.
The Africa Cancer Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Africa Cancer Therapeutics Market report:
The Africa Cancer Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Africa Cancer Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Africa Cancer Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Africa Cancer Therapeutics Market
